Literature DB >> 23442572

Surveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in south India.

K D Ramaiah1, P Vanamail.   

Abstract

BACKGROUND: While various studies provided insight into the impact of mass drug administration (MDA), information on the dynamics of the post-MDA threshold level lymphatic filariasis (LF) infection facilitates understanding its disappearance pattern and determining the duration of post-MDA monitoring and evaluation.
METHODS: The changes in microfilaraemia (Mf) prevalence and vector infection rates were monitored for four (2005-2008) and six years (2005-2010) respectively after stopping ten rounds of annual mass diethylcarbamazine (DEC) administration in a group of five villages located in South India. Four years after stopping MDA, circulating filarial antigenaemia (Ag) status among children and adults was also assessed in two villages.
RESULTS: Overall Mf prevalence (n = 700) and vector infection rates (n=803-3520) showed a declining trend. Two villages maintained zero Mf status in each of the four years, vector infection rate was zero from the third year onwards and Ag prevalence in adults was 0.4% (n = 226). In two other villages despite persistence of Mf and vector infection there was zero vector infectivity rate during the third to sixth year and Ag prevalence among children (n = 50) was nil. In the fifth village Mf prevailed at <1.0% and Ag prevalence among 1-7 year old children was 4.6% (n = 44) and vector infectivity rate during the sixth year was 0.1% (n = 852).
CONCLUSION: The incidence of sporadic new infections is evident in highly endemic communities such as the fifth village. However, there is uncertainty on the potential of the Ag positive children to reestablish infection. Six years of post-MDA monitoring and evaluation appears to be adequate to discern the status of transmission interruption and appropriate decision making.

Entities:  

Mesh:

Year:  2013        PMID: 23442572     DOI: 10.1093/trstmh/trt011

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Rapid diagnostics for the endgame in lymphatic filariasis elimination.

Authors:  Maria P Rebollo; Moses J Bockarie
Journal:  Am J Trop Med Hyg       Date:  2013-07       Impact factor: 2.345

2.  Highly heterogeneous, activated, and short-lived regulatory T cells during chronic filarial infection.

Authors:  Simon Metenou; Yaya I Coulibaly; Daniel Sturdevant; Housseini Dolo; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Kishore Kanakabandi; Stephen F Porcella; Amy D Klion; Thomas B Nutman
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

3.  Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.

Authors:  Yaya I Coulibaly; Siaka Y Coulibaly; Housseini Dolo; Siaka Konate; Abdallah A Diallo; Salif S Doumbia; Lamine Soumaoro; Michel E Coulibaly; Ilo Dicko; Moussa B Sangare; Benoit Dembele; Modibo Sangare; Massitan Dembele; Yeya T Touré; Louise Kelly-Hope; Katja Polman; Dominique Kyelem; Sekou F Traore; Moses Bockarie; Amy D Klion; Thomas B Nutman
Journal:  Parasit Vectors       Date:  2016-12-03       Impact factor: 3.876

4.  Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.

Authors:  Morgan E Smith; Brajendra K Singh; Edwin Michael
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

5.  First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.

Authors:  Hugues C Nana-Djeunga; Magellan Tchouakui; Guy R Njitchouang; Jules B Tchatchueng-Mbougua; Philippe Nwane; André Domche; Jean Bopda; Stève Mbickmen-Tchana; Julie Akame; Ann Tarini; Emilienne Epée; Benjamin D Biholong; Yaobi Zhang; Jean J Tougoue; Achille Kabore; Flobert Njiokou; Joseph Kamgno
Journal:  PLoS Negl Trop Dis       Date:  2017-06-29

6.  Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.

Authors:  Anjali Modi; Sukesha Gamit; Bharat S Jesalpura; George Kurien; Jayendra K Kosambiya
Journal:  PLoS Negl Trop Dis       Date:  2017-04-03

7.  Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil.

Authors:  Anita Ramesh; Mary Cameron; Kirstin Spence; Remy Hoek Spaans; Maria A V Melo-Santos; Marcelo H S Paiva; Duschinka R D Guedes; Rosangela M R Barbosa; Claudia M F Oliveira; André Sá; Claire L Jeffries; Priscila M S Castanha; Paula A S Oliveira; Thomas Walker; Neal Alexander; Cynthia Braga
Journal:  PLoS Negl Trop Dis       Date:  2018-10-16

8.  A Novel Xenomonitoring Technique Using Mosquito Excreta/Feces for the Detection of Filarial Parasites and Malaria.

Authors:  Nils Pilotte; Weam I Zaky; Brian P Abrams; Dave D Chadee; Steven A Williams
Journal:  PLoS Negl Trop Dis       Date:  2016-04-20

9.  Rapid progress towards elimination of lymphatic filariasis in endemic regions of Myanmar as a result of 16 years of anti-filarial activities (2001-2016).

Authors:  Kyawt Mon Win; Jaya Prasad Tripathy; Thae Maung Maung; Tin Oo; Aung Thi; Khin Nan Lon; Zaw Lin
Journal:  Trop Med Health       Date:  2018-04-16

10.  A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings.

Authors:  Nicholas Riches; Xavier Badia-Rius; Themba Mzilahowa; Louise A Kelly-Hope
Journal:  PLoS Negl Trop Dis       Date:  2020-05-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.